A case-based approach to evaluating azithromycin use and cardiovascular risks

Consultant Pharmacist

Volumn 29, Issue 1, 2014, Pages 47-52

  Wong, Elaine ^a   Nguyen, Timothy V ^a  

^a LONG ISLAND UNIVERSITY   (United States)

Author keywords

Arrhythmias; Azithromycin; Community acquired pneumonia; Macrolides; Methadone; QT prolongation; Risperidone; Torsade de pointes

Indexed keywords

AZITHROMYCIN; METHADONE; PARACETAMOL; RISPERIDONE;

AGED; ARTICLE; CARDIOVASCULAR RISK; COMMUNITY ACQUIRED PNEUMONIA; HEART ARRHYTHMIA; HUMAN; MALE; QT PROLONGATION;

ARRHYTHMIAS; AZITHROMYCIN; CAP = COMMUNITY-ACQUIRED PNEUMONIA; COMMUNITY-ACQUIRED PNEUMONIA; ICU = INTENSIVE CARE UNIT; IDSA = INFECTIOUS DISEASES SOCIETY OF AMERICA; MACROLIDES; METHADONE; QT-PROLONGATION; RISPERIDONE; TORSADE DE POINTES;

AGED; ANTI-BACTERIAL AGENTS; ARRHYTHMIAS, CARDIAC; AZITHROMYCIN; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; LONG QT SYNDROME; MALE; PNEUMONIA, BACTERIAL; RISK;

EID: 84892728368     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2014.47     Document Type: Article

References (19)

1. Brar NK, Niederman MS. Management of community-acquired pneumonia. Ther Adv Resp Dis 2011;5:61-78.
2. Mandall LA, Wunderink RG, Anzueto A et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44:S27.
3. CDC. Pneumonia can be prevented - vaccines can help. Available at www.cdc.gov/features/pneumonia. Accessed March 8, 2013.
4. IMS Institute for Healthcare Informatics. The use of medicines in the United States review of 2011. Available at http://www.imshealth.com/ims/Global/ Content/Insights/IMS%20Institute%20for%20Healthcare%20Informatics/ IHII-Medicines-in-U.S-Report-2011.pdf. Accessed February 28, 2013.
5. Zithromax (azithromycin) tablets and oral suspension [prescribing information]. New York, NY: Pfizer Labs; 2013.
6. Ray WA, Murray KT, Hall K et al. Azithromycin and the risk of CV death. N Engl J Med 2012;366:1881-90.
7. Micromedex Healthcare Series [internet database]. Greenwood Village, CO: Thomson Healthcare; updated periodically. Accessed March 21, 2013.
8. Owens RC, Nolin TD. Antimicrobial-associated QT prolongation: pointes of interest. Clin Infect Dis 2006;43:1603-11.
9. Food and Drug Administration. FDA Statement regarding azithromycin (Zithromax) and the risk of CV death [05-17-2012]. Available at http://www.fda.gov/Drugs/DrugSafety/ucm304372.htm. Accessed March 15, 2013.
10. Food and Drug Administration. FDA Drug Safety Communication: Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms [3-12-2013]. Available at http://www.fda.gov/drugs/drugsafety/ucm341822.Htm. Accessed March 15, 2013.
11. Gupta A, Lawrence AT, Krishnan K et al. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am Heart J 2007;153:891-9.
12. Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart 2003;89:1363-72.
13. Dolophine hydrochloride CII (methadone hydrochloride tablets, USP) [prescribing information]. Columbus, OH: Roxane Laboratories, Inc.; 2006. Available at http://www.accessdata.fda.gov/drugsatfda-docs/label/2006/ 006134s028lbl.pdf. Accessed April 18, 2013.
14. Krantz MJ, Lewkowiez L, Hays H et al. Torsade de pointes associated with very-high-dose methadone. Ann Intern Med 2002;137:501-4.
15. Krantz MJ, Mehler PS. QTc prolongation: methadone's efficacy-safety paradox. Lancet 2006;368:556-7.
16. Stringer JS, Welsh C, Tommasello A. Methadone-associated Q-T prolongation and torsades de pointes. Am J Health Syst Pharm 2009;66:825-33.
17. Glassman AH, Thomas Bigger, Jr. J. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 2001;158:1774-82.
18. Drew BJ, Califf RM, Funk M et al. Practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association scientific statement from Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: endorsed by the International Society of Computerized Electrocardiology and the American Association of Critical Care Nurses. Circulation 2004;110:2721-46.
19. Drew BJ, Ackerman MJ, Funk M et al. On behalf of the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology, the Council on Cardiovascular Nursing, and the American College of Cardiology Foundation. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation 2010;121:1047-60.